Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Intervention1: Group L- Intravenous Lignocaine infusion (test group): Patients in this group will receive a 1.5 mg/kg loading dose of 2% lidocaine solution via IV infusion, administered slowly over 3-
Sponsors
Post Graduate Institute Of Medical Education And Research,Chandigarh
Eligibility
Inclusion criteria
Inclusion criteria: ASA I and II female patient undergoing unilateral mastectomy.
Exclusion criteria
Exclusion criteria: Patient refuses to participate, unable to understand the VAS score, with pre-existing infection at the site of block, with morbid obesity and sensitive to local anaesthetic
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Area under the curve (AUC) of the visual analog score (VAS) sccore of pain vs time over 24hrTimepoint: At 0hr, 0.5hr, 1hr, 2hr, 4hr, 6hr, 8hr, 12hr and 24hr in postoperative period | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain score (VAS)Timepoint: 0hr, 0.5hr, 1hr, 2hr, 4hr, 6hr, 8hr, 12hr, 24hr and 3 month after surgery;Postoperative nausea vomiting number of episodes, dose of antiemetics requiredTimepoint: post operative period;Time to 1st rescue analgesiaTimepoint: ;Cumulative dose of rescue analgesiaTimepoint: ;Quality of recovery score QoR-15Timepoint: ;Richmond agitation sedation score (RASS) for lignocaine infusionTimepoint: ;Complications for E.g. LA toxicity, vascular puncture, pleural puncture.Timepoint: | — |
Countries
India
Contacts
Public ContactAshish Singh Aditya
Post Graduate Institute of Medical Education and Research
Outcome results
None listed